H F Vöhringer

590 total citations
11 papers, 407 citations indexed

About

H F Vöhringer is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, H F Vöhringer has authored 11 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Infectious Diseases and 3 papers in Pharmacology. Recurrent topics in H F Vöhringer's work include Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pneumonia and Respiratory Infections (3 papers) and Drug-Induced Adverse Reactions (3 papers). H F Vöhringer is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pneumonia and Respiratory Infections (3 papers) and Drug-Induced Adverse Reactions (3 papers). H F Vöhringer collaborates with scholars based in Germany, Belgium and United States. H F Vöhringer's co-authors include G. Biamino, Thomas Brüggemann, Rolf Schröder, T. Linderer, Karl Wegscheider, Eva Leitner, J Heitz, Norbert Rietbrock, Barry G. Woodcock and Enz-Rüdiger von Leitner and has published in prestigious journals such as Circulation, The American Journal of Cardiology and Clinical Pharmacology & Therapeutics.

In The Last Decade

H F Vöhringer

11 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H F Vöhringer Germany	5	292	162	127	48	44	11	407
Harbans S. Wasir India	13	360 1.2×	206 1.3×	65 0.5×	98 2.0×	89 2.0×	28	505
Winfried Haerer Germany	8	211 0.7×	113 0.7×	61 0.5×	51 1.1×	72 1.6×	29	346
Rakhi Kilaru United States	15	473 1.6×	193 1.2×	81 0.6×	28 0.6×	36 0.8×	20	574
Walter E. Kelley United States	9	255 0.9×	81 0.5×	127 1.0×	46 1.0×	40 0.9×	22	490
Sima Welber Israel	9	392 1.3×	212 1.3×	175 1.4×	33 0.7×	46 1.0×	18	503
M Metcalfe United Kingdom	12	350 1.2×	84 0.5×	195 1.5×	16 0.3×	38 0.9×	30	526
Stamatis S. Makrygiannis Greece	11	261 0.9×	84 0.5×	77 0.6×	56 1.2×	28 0.6×	20	389
G. S. Hale Australia	10	218 0.7×	71 0.4×	56 0.4×	86 1.8×	50 1.1×	20	404
F Rovelli Italy	8	583 2.0×	168 1.0×	161 1.3×	39 0.8×	39 0.9×	29	680
Antonio Di Chiara Italy	12	449 1.5×	165 1.0×	138 1.1×	54 1.1×	13 0.3×	31	619

Countries citing papers authored by H F Vöhringer

Since Specialization

Citations

This map shows the geographic impact of H F Vöhringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H F Vöhringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H F Vöhringer more than expected).

Fields of papers citing papers by H F Vöhringer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H F Vöhringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H F Vöhringer. The network helps show where H F Vöhringer may publish in the future.

Co-authorship network of co-authors of H F Vöhringer

This figure shows the co-authorship network connecting the top 25 collaborators of H F Vöhringer. A scholar is included among the top collaborators of H F Vöhringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H F Vöhringer. H F Vöhringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Zeymer, Uwe, Ulrich Tebbe, Michael A. Weber, et al.. (2003). Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.. PubMed. 15(7). 385–9. 14 indexed citations

Vöhringer, H F, et al.. (1994). Pentamidine Aerosol vs Cotrimoxazole in the Treatment of Slight to Moderate Pneumocystis carinii Pneumonia. Clinical Drug Investigation. 8(6). 321–330. 1 indexed citations

Vöhringer, H F, et al.. (1993). Pharmacokinetics and Adverse Reactions of Various Dosage Regimens of Intravenous Pentamidine in the Treatment of HIV-Associated Pneumocystis carinii Pneumonia. Clinical Drug Investigation. 6(4). 207–217. 1 indexed citations

Link, H., et al.. (1993). Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT.. PubMed. 11(5). 403–6. 24 indexed citations

Vöhringer, H F, et al.. (1992). [Determinants of serum pentamidine concentration in the human].. PubMed. 87 Suppl 1. 24–9. 3 indexed citations

Link, H., et al.. (1992). [Risk factors and prevention of pneumocystis carinii pneumonia after bone marrow transplantation].. PubMed. 87 Suppl 1. 39–42. 1 indexed citations

Link, H., et al.. (1990). [Initial experiences with pentamidine aerosol in prevention of Pneumocystis carinii pneumonia following bone marrow transplantation].. PubMed. 85 Suppl 2. 288–90. 1 indexed citations

Vöhringer, H F, et al.. (1990). [Pharmacologic studies with pentamidine aerosol in HIV patients].. PubMed. 85 Suppl 2. 248–50, 291. 1 indexed citations

Schröder, Rolf, H F Vöhringer, Thomas Linderer, et al.. (1985). Follow-up after coronary arterial reperfusion with intravenous streptokinase in relation to residual myocardial infarct artery narrowings. The American Journal of Cardiology. 55(4). 313–317. 41 indexed citations

10.

Schröder, Rolf, G. Biamino, Eva Leitner, et al.. (1983). Intravenous short-term infusion of streptokinase in acute myocardial infarction.. Circulation. 67(3). 536–548. 255 indexed citations

11.

Woodcock, Barry G., et al.. (1981). Verapamil disposition in liver disease and intensive-care patients: Kinetics, clearance, and apparent blood flow relationships. Clinical Pharmacology & Therapeutics. 29(1). 27–34. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact